Gene · 910
Papers2,023
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,023
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High Efficacy and Drug Synergy of HDAC6-Selective Inhibitor NN-429 in Natural Killer (NK)/T-Cell Lymphoma. | Pharmaceuticals (Basel) | 2022 | 36355493 | PubTator, text mining | PubMed |
| Development of Fluorinated Peptoid-Based Histone Deacetylase (HDAC) Inhibitors for Therapy-Resistant Acute Leukemia. | J Med Chem | 2022 | 36351184 | PubTator, text mining | PubMed |
| CD1d-dependent rewiring of lipid metabolism in macrophages regulates innate immune responses. | Nat Commun | 2022 | 36344546 | PubTator, text mining | PubMed |
| An improved Fuzzy based GWO algorithm for predicting the potential host receptor of COVID-19 infection. | Comput Biol Med | 2022 | 36334362 | PubTator, text mining | PubMed |
| Integration of a clinical pharmacist workforce into newly forming primary care networks: a qualitatively driven, complex systems analysis. | BMJ Open | 2022 | 36328385 | PubTator, text mining | PubMed |
| Shared genetic risk factors and causal association between psoriasis and coronary artery disease. | Nat Commun | 2022 | 36323703 | PubTator, text mining | PubMed |
| The liver-resident immune cell repertoire - A boon or a bane during machine perfusion? | Front Immunol | 2022 | 36311746 | PubTator, text mining | PubMed |
| Molecular Analysis of the Melanogenesis Inhibitory Effect of Saponins-Rich Fraction of Argania spinosa Leaves Extract. | Molecules | 2022 | 36235295 | PubTator, text mining | PubMed |
| Dendritic Cells: The Long and Evolving Road towards Successful Targetability in Cancer. | Cells | 2022 | 36230990 | PubTator, text mining | PubMed |
Systematic evaluation of tumor microenvironment and construction of a machine learning model to predict prognosis and immunotherapy efficacy in triple-negative breast cancer based on data mining and sequencing validation. | Front Pharmacol | 2022 | 36225561 | PubTator, text mining | PubMed |
| Multiomics surface receptor profiling of the NCI-60 tumor cell panel uncovers novel theranostics for cancer immunotherapy. | Cancer Cell Int | 2022 | 36221114 | PubTator, text mining | PubMed |
| Novel six-gene prognostic signature based on colon adenocarcinoma immune-related genes. | BMC Bioinformatics | 2022 | 36221049 | PubTator, text mining | PubMed |
| A high-dimensional cytometry atlas of peripheral blood over the human life span. | Immunol Cell Biol | 2022 | 36218032 | PubTator, text mining | PubMed |
| Identification of CD98 as a Novel Biomarker for HIV-1 Permissiveness and Latent Infection. | mBio | 2022 | 36214569 | PubTator, text mining | PubMed |
| Recent Developments in Drug Delivery for Treatment of Tuberculosis by Targeting Macrophages. | Adv Ther (Weinh) | 2022 | 36203881 | PubTator, text mining | PubMed |
| Beyond darunavir: recent development of next generation HIV-1 protease inhibitors to combat drug resistance. | Chem Commun (Camb) | 2022 | 36200462 | PubTator, text mining | PubMed |
| Decreased Polymorphonuclear Myeloid-Derived Suppressor Cells and ROS Production Correlated Closely with Bronchopulmonary Dysplasia in Preterm Infants. | Oxid Med Cell Longev | 2022 | 36193058 | PubTator, text mining | PubMed |
| Adaptive immunity in different CT patterns of active tuberculosis and possible variability according to patients' geographic provenience. | Front Med (Lausanne) | 2022 | 36160177 | PubTator, text mining | PubMed |
| A specialized tyrosine-based endocytosis signal in MR1 controls antigen presentation to MAIT cells. | J Cell Biol | 2022 | 36129434 | PubTator, text mining | PubMed |
| Single-cell transcriptome reveals cellular hierarchies and guides p-EMT-targeted trial in skull base chordoma. | Cell Discov | 2022 | 36127333 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/910/papers?page=12